Crescent Biopharma, Inc.

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Other events Jul 15, 2026 8-K Results of operations (earnings release) Jul 14, 2026 10-Q/A Quarter ended 2026-03-31 Jun 22, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Results of operations (earnings release) Apr 29, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change Jul 31, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure Jun 18, 2025 8-K Shareholder vote results; Regulation FD disclosure; Other events Jun 6, 2025 8-K Other events May 30, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Entered a material agreement Apr 29, 2025 8-K Terminated a material agreement; Director or officer change Feb 25, 2025 8-K Entered a material agreement Feb 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 13, 2025 8-K Director or officer change Jan 31, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Delisting notice or listing-rule failure Dec 26, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Regulation FD disclosure Nov 7, 2024 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure; Other events Oct 29, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Jul 30, 2024 8-K Delisting notice or listing-rule failure Jun 26, 2024 8-K Director or officer change Jun 13, 2024 8-K Regulation FD disclosure Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2024 8-K Amended charter or bylaws; Shareholder vote results May 2, 2024 8-K Results of operations (earnings release) Mar 27, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Regulation FD disclosure Mar 1, 2024